pI: 5.3072 |
Length (AA): 149 |
MW (Da): 17057 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 140 | 1twf (H) | 2 | 146 | 37.00 | 0 | 1 | 1.31 | -0.38 |
2 | 140 | 3h0g (H) | 2 | 125 | 41.00 | 0 | 0.86 | 1.22289 | 0.61 |
3 | 140 | 3cqz (H) | 2 | 146 | 41.00 | 0 | 1 | 1.13537 | 0.13 |
5 | 140 | 3gtj (H) | 4 | 146 | 36.00 | 0 | 0.95 | 1.27975 | 0.25 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 merozoite. | Gregory Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127936)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G59600 | RNA polymerase Rpb8 |
Arabidopsis thaliana | AT1G54250 | DNA-directed RNA polymerases II and V subunit 8A |
Babesia bovis | BBOV_IV005100 | RNA polymerase subunit 8c, putative |
Brugia malayi | Bm1_26995 | DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide |
Candida albicans | CaO19.6314 | 16-kDa RNA polymerase subunit |
Candida albicans | CaO19.13691 | 16-kDa RNA polymerase subunit |
Caenorhabditis elegans | CELE_F26F4.11 | Protein RPB-8 |
Cryptosporidium hominis | Chro.10257 | RNA polymerase subunit 8c |
Cryptosporidium parvum | cgd1_2260 | RNA polymerase II B8 subunit |
Dictyostelium discoideum | DDB_G0278039 | RNA polymerase I core subunit |
Drosophila melanogaster | Dmel_CG11246 | CG11246 gene product from transcript CG11246-RA |
Echinococcus granulosus | EgrG_000117600 | dna directed rna polymerases i ii and iii |
Entamoeba histolytica | EHI_038570 | RNA polymerase subunit Rpb8 |
Echinococcus multilocularis | EmuJ_000117600 | dna directed rna polymerases i ii and iii |
Giardia lamblia | GL50803_15144 | RNA polymerase II subunit Rpb8 |
Homo sapiens | ENSG00000163882 | polymerase (RNA) II (DNA directed) polypeptide H |
Leishmania braziliensis | LbrM.28.0850 | RNA polymerase B subunit RPB8, putative |
Leishmania donovani | LdBPK_280870.1 | RNA polymerase B subunit RPB8, putative |
Leishmania infantum | LinJ.28.0870 | RNA polymerase B subunit RPB8, putative |
Leishmania major | LmjF.28.0810 | RNA polymerase B subunit RPB8, putative |
Leishmania mexicana | LmxM.28.0810 | RNA polymerase B subunit RPB8, putative |
Loa Loa (eye worm) | LOAG_00799 | DNA-directed RNA polymerase I |
Mus musculus | ENSMUSG00000021018 | polymerase (RNA) II (DNA directed) polypeptide H |
Mus musculus | 102640226 | DNA-directed RNA polymerases I, II, and III subunit RPABC3-like |
Neospora caninum | NCLIV_033350 | UDP-glucose 4-epimerase Gal10, related |
Oryza sativa | 4341946 | Os06g0697400 |
Oryza sativa | 4334766 | Os03g0845700 |
Plasmodium berghei | PBANKA_1429500 | DNA-directed RNA polymerases I, II, and III subunit RPABC3, putative |
Plasmodium falciparum | PF3D7_1213700 | DNA-directed RNA polymerases I, II, and III subunit RPABC3, putative |
Plasmodium knowlesi | PKNH_1433200 | DNA-directed RNA polymerases I, II, and III subunit RPABC3, putative |
Plasmodium vivax | PVX_123375 | RNA polymerase subunit 8c, putative |
Plasmodium yoelii | PY02017 | DNA-directed RNA polymerases i, ii, and iii 17.1 kDa polypeptide |
Saccharomyces cerevisiae | YOR224C | DNA-directed RNA polymerase core subunit RPB8 |
Schistosoma japonicum | Sjp_0070380 | ko:K03016 DNA-directed RNA polymerase II subunit H, putative |
Schistosoma mansoni | Smp_006850 | DNA-directed rna polymerase subunit rpb8 |
Schmidtea mediterranea | mk4.004862.04 | Probable DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
Schmidtea mediterranea | mk4.007396.00 | Probable DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
Trypanosoma brucei gambiense | Tbg972.11.9040 | RNA polymerase B subunit RPB8, putative |
Trypanosoma brucei | Tb927.11.7930 | RNA polymerase B subunit RPB8, putative |
Trypanosoma cruzi | TcCLB.506933.80 | RNA polymerase B subunit RPB8, putative |
Toxoplasma gondii | TGME49_233720 | DNA-directed RNA polymerase II RPBABC8 |
Theileria parva | TP01_0233 | RNA polymerase subunit, putative |
Trichomonas vaginalis | TVAG_186530 | DNA-directed RNA polymerase subunit rpb8, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.5790 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.5790 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.5790 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.5790 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F26F4.11 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F26F4.11 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F26F4.11 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F26F4.11 | Caenorhabditis elegans | sterile | wormbase |
YOR224C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_233720 this record | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.